Skip to Main Content

Author Details

Susan E Abbatiello
The Barnett Institute of Chemical and Biological Analysis, Northeastern University
2005
25
18
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35084980The Blood Proteoform Atlas: A reference map of proteoforms in human hematopoietic cells.Science2022
36012232Characterization of Calpain and Caspase-6-Generated Glial Fibrillary Acidic Protein Breakdown Products Following Traumatic Brain Injury and Astroglial Cell Injury.Int J Mol Sci2022
35084980The Blood Proteoform Atlas: A reference map of proteoforms in human hematopoietic cells.Science2022
36012232Characterization of Calpain and Caspase-6-Generated Glial Fibrillary Acidic Protein Breakdown Products Following Traumatic Brain Injury and Astroglial Cell Injury.Int J Mol Sci2022
33844503Deeper Protein Identification Using Field Asymmetric Ion Mobility Spectrometry in Top-Down Proteomics.Anal Chem2021
33844503Deeper Protein Identification Using Field Asymmetric Ion Mobility Spectrometry in Top-Down Proteomics.Anal Chem2021
32134636Correction to Characterization and Optimization of Multiplexed Quantitative Analyses Using High-Field Asymmetric-Waveform Ion Mobility Mass Spectrometry.Anal Chem2020
31967787Comprehensive LESA Mass Spectrometry Imaging of Intact Proteins by Integration of Cylindrical FAIMS.Anal Chem2020
32134636Correction to Characterization and Optimization of Multiplexed Quantitative Analyses Using High-Field Asymmetric-Waveform Ion Mobility Mass Spectrometry.Anal Chem2020
32628755From Skepticism to Embrace: The Role of Targeted Mass Spectrometry in Validating Proteomics.Clin Chem2020
33054160Improved Sensitivity of Ultralow Flow LC-MS-Based Proteomic Profiling of Limited Samples Using Monolithic Capillary Columns and FAIMS Technology.Anal Chem2020
31967787Comprehensive LESA Mass Spectrometry Imaging of Intact Proteins by Integration of Cylindrical FAIMS.Anal Chem2020
33054160Improved Sensitivity of Ultralow Flow LC-MS-Based Proteomic Profiling of Limited Samples Using Monolithic Capillary Columns and FAIMS Technology.Anal Chem2020
32628755From Skepticism to Embrace: The Role of Targeted Mass Spectrometry in Validating Proteomics.Clin Chem2020
30672687Characterization and Optimization of Multiplexed Quantitative Analyses Using High-Field Asymmetric-Waveform Ion Mobility Mass Spectrometry.Anal Chem2019
30672687Characterization and Optimization of Multiplexed Quantitative Analyses Using High-Field Asymmetric-Waveform Ion Mobility Mass Spectrometry.Anal Chem2019
29438992Nonlinear Regression Improves Accuracy of Characterization of Multiplexed Mass Spectrometric Assays.Mol Cell Proteomics2018
29969236Comprehensive Single-Shot Proteomics with FAIMS on a Hybrid Orbitrap Mass Spectrometer.Anal Chem2018
29438992Nonlinear Regression Improves Accuracy of Characterization of Multiplexed Mass Spectrometric Assays.Mol Cell Proteomics2018
29969236Comprehensive Single-Shot Proteomics with FAIMS on a Hybrid Orbitrap Mass Spectrometer.Anal Chem2018
28183812New Guidelines for Publication of Manuscripts Describing Development and Application of Targeted Mass Spectrometry Measurements of Peptides and Proteins.Mol Cell Proteomics2017
28483925MSstatsQC: Longitudinal System Suitability Monitoring and Quality Control for Targeted Proteomic Experiments.Mol Cell Proteomics2017
28183812New Guidelines for Publication of Manuscripts Describing Development and Application of Targeted Mass Spectrometry Measurements of Peptides and Proteins.Mol Cell Proteomics2017
28483925MSstatsQC: Longitudinal System Suitability Monitoring and Quality Control for Targeted Proteomic Experiments.Mol Cell Proteomics2017
26912667Reduced-representation Phosphosignatures Measured by Quantitative Targeted MS Capture Cellular States and Enable Large-scale Comparison of Drug-induced Phenotypes.Mol Cell Proteomics2016
26912667Reduced-representation Phosphosignatures Measured by Quantitative Targeted MS Capture Cellular States and Enable Large-scale Comparison of Drug-induced Phenotypes.Mol Cell Proteomics2016
25693799Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma.Mol Cell Proteomics2015
25693799Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma.Mol Cell Proteomics2015
24443746Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach.Mol Cell Proteomics2014
24317253Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins.Nat Methods2014
24443746Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach.Mol Cell Proteomics2014
24813211A framework for installable external tools in Skyline.Bioinformatics2014
24813211A framework for installable external tools in Skyline.Bioinformatics2014
24317253Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins.Nat Methods2014
23689285Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS).Mol Cell Proteomics2013
23689285Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS).Mol Cell Proteomics2013
23176545Statistical characterization of multiple-reaction monitoring mass spectrometry (MRM-MS) assays for quantitative proteomics.BMC Bioinformatics2012
23176545Statistical characterization of multiple-reaction monitoring mass spectrometry (MRM-MS) assays for quantitative proteomics.BMC Bioinformatics2012
21245105Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry.Mol Cell Proteomics2011
21245105Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry.Mol Cell Proteomics2011
20022980Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry.Clin Chem2010
21090646Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry.Anal Chem2010
20022980Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry.Clin Chem2010
21090646Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry.Anal Chem2010
19561596Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.Nat Biotechnol2009
19561596Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.Nat Biotechnol2009
18541474Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients.J Proteomics2008
18541474Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients.J Proteomics2008
16023613Efficient expression, purification, and characterization of C-terminally tagged, recombinant human asparagine synthetase.Arch Biochem Biophys2005
16023613Efficient expression, purification, and characterization of C-terminally tagged, recombinant human asparagine synthetase.Arch Biochem Biophys2005
  • 1 - 50 of 50

Recommended Authors

KTH Royal Institute of Technology
Career Start Year 2018
Number of shared co-authors 1
KTH Royal Institute of Technology
Career Start Year 2014
Number of shared co-authors 2
Buck Institute for Research on Aging, Cedars-Sinai Medical Center
Career Start Year 2012
Number of shared co-authors 3
Pacific Northwest National Laboratory
Career Start Year 2011
Number of shared co-authors 5
Institute for Systems Biology
Career Start Year 2007
Number of shared co-authors 10
Queen's University of Belfast
Career Start Year 2007
Number of shared co-authors 10
Genentech Inc.
Career Start Year 2006
Number of shared co-authors 15
Pacific Northwest National Laboratory
Career Start Year 2006
Number of shared co-authors 5
Nuclea Biotechnologies
Career Start Year 2005
Number of shared co-authors 2
Pacific Northwest National Laboratory
Career Start Year 2004
Number of shared co-authors 10
Pacific Northwest National Laboratory
Career Start Year 2004
Number of shared co-authors 7
Stanford University
Career Start Year 2003
Number of shared co-authors 10
Center for Proteomics and Metabolomics, Leiden University Medical Center
Career Start Year 2003
Number of shared co-authors 3
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Career Start Year 2002
Number of shared co-authors 3
Pacific Northwest National Laboratory
Career Start Year 2000
Number of shared co-authors 7
Boston Children's Hospital, USA Harvard Medical School, Harvard Medical School
Career Start Year 2000
Number of shared co-authors 4
Center for Proteomics and Metabolomics, Leiden University Medical Center
Career Start Year 1999
Number of shared co-authors 11
Groningen Research Institute of Pharmacy, University of Groningen
Career Start Year 1999
Number of shared co-authors 3
Harvard Partners Center For Genetics and Genomics
Career Start Year 1998
Number of shared co-authors 1
Cedars-Sinai Medical Center
Career Start Year 1998
Number of shared co-authors 2
University of Pittsburgh School of Medicine
Career Start Year 1996
Number of shared co-authors 12
Pacific Northwest National Laboratory
Career Start Year 1994
Number of shared co-authors 18
University of Michigan ann arbor
Career Start Year 1994
Number of shared co-authors 21
Memorial Sloan Kettering Cancer Center
Career Start Year 1990
Number of shared co-authors 10
University of Victoria
Career Start Year 1988
Number of shared co-authors 13
University of Minnesota
Career Start Year 1985
Number of shared co-authors 2
Center for Genomic and Computational Biology
Career Start Year 1985
Number of shared co-authors 3
Addenbrooke's Hospital, University of Cambridge
Career Start Year 1985
Number of shared co-authors 2
Groningen Research Institute of Pharmacy, University of Groningen
Career Start Year 1982
Number of shared co-authors 3
Pacific Northwest National Laboratory
Career Start Year 1964
Number of shared co-authors 18

Collaborators

Broad Institute of MIT and Harvard
Co-authored papers 13
Co-authored papers 8
Co-authored papers 7
Co-authored papers 7
University of Washington
Co-authored papers 6
Co-authored papers 6
McGill University
Co-authored papers 5
Co-authored papers 5
Khoury College of Computer Sciences, Northeastern University
Co-authored papers 5
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Buck Institute for Research on Aging
Co-authored papers 5
The Buck Institute for Research on Aging
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
University of California San Francisco
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Neuroscience Institute, NYU Grossman School of Medicine
Co-authored papers 3
Co-authored papers 3